Essentially, the activation of PGR downstream pathways with SAG rescued the abnormal epithelial proliferation in Cfp1d/d uterus (Fig. 3) and suppressed the ectopic growth of Cfp1d/d uterine lesions with P4 resistance in the endometriosis model (Fig. 4). The gene discussed is SAG; the disease is endometriosis.